Emma Ito
Papers
1
Total Citations
63
H-Index
1
About
Dr. Emma Ito is a pioneering cancer biologist whose work has fundamentally improved the efficiency and scalability of preclinical drug screening. Her primary research focuses on optimizing in vitro assays to accelerate the discovery of effective combination therapies. Dr. Ito’s most impactful contribution is her seminal 2008 paper on adapting the traditional colony formation assay (CFA)—the gold standard for measuring cytotoxic effects—to a 96-well plate format. This innovation, which has garnered 63 citations, dramatically reduced the time and labor required for evaluating drug combinations, enabling high-throughput screening that was previously impractical. By solving a critical bottleneck in cancer research, her work has directly facilitated the rapid testing of novel therapeutic pairings, making her a key figure in translational oncology. Dr. Ito’s methodological advancements continue to empower laboratories worldwide, bridging the gap between basic cancer biology and clinical application.
Research Focus
Key Achievements
Top Papers
- 1